IceCure Medical CEO Issues Letter to Shareholders

/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...

Related Keywords

Japan ,United States ,Thailand ,India ,Marianna ,Estado De Pernambuco ,Brazil ,Israel ,Singapore ,China ,Poland ,Turkey ,America ,American ,Kenneth Tomkovich ,As Mutlu Medikim ,Eyal Shamir ,Mutlu Medikim Tibbi Malzeme ,Hisanori Kawamoto ,Chuck Padala ,European Patent Office ,Breast Center ,Company Registration Statement On Form ,American Society Of Breast Surgeons ,Nasdaq ,Terumo Corporation ,Radiological Society Of North America ,Terumo Corporation Tokyo ,Marianna University School Of Medicine ,Drug Administration ,Radiologists Society Of North America ,Research Clinical ,Novomed Ltd ,Imaging Center ,Department Of Breast Surgery ,Icecure Medical Ltd ,National Medical Products Administration ,Icecure Medical ,Chief Executive Officer ,American Society ,Breast Surgeons ,Radiological Society ,North America ,Human Resources ,Prosense System ,Breakthrough Device Designation ,Annual Meeting ,Co Primary Investigator ,Radiologists Society ,Without Excision ,Early Stage Breast Cancer ,Year Interim Analysis ,Ipsilateral Breast Tumor Recurrence ,Surgical Oncology ,Richard Fine ,Program Director ,Breast Surgical Oncology Fellowship ,West Comprehensive Breast Center ,Percutaneous Ultra Sound Guided Cryoablation ,Primary Early Stage Breast Cancer ,Pilot Study ,Cancer Therapy ,Breast Surgery ,Marianna University School ,Nasdaq Capital Market ,Israel Based Icecure Medical ,Private Securities Litigation Reform Act ,Risk Factors ,Registration Statement ,